ALS-causative mutations in FUS/TLS confer gain- and loss-of-function by altered association with SMN and U1-snRNP
Albuquerque, Claudio P.
Yeo, Gene W.
Huang, Eric J.
Cleveland, Don W.Note: Order does not necessarily reflect citation order of authors.
MetadataShow full item record
CitationSun, S., S. Ling, J. Qiu, C. P. Albuquerque, Y. Zhou, S. Tokunaga, H. Li, et al. 2015. “ALS-causative mutations in FUS/TLS confer gain- and loss-of-function by altered association with SMN and U1-snRNP.” Nature communications 6 (1): 6171. doi:10.1038/ncomms7171. http://dx.doi.org/10.1038/ncomms7171.
AbstractThe RNA-binding protein FUS/TLS, mutation in which is causative of the fatal motor neuron disease ALS, is demonstrated to directly bind to the U1-snRNP and SMN complexes. ALS-causative mutations in FUS/TLS are shown to abnormally enhance their interaction with SMN and dysregulate its function, including loss of Gems and altered levels of small nuclear RNAs (snRNAs). The same mutants are found to have reduced association with U1-snRNP. Correspondingly, global RNA analysis reveals a mutant-dependent loss of splicing activity, with ALS-linked mutants failing to reverse changes caused by loss of wild-type FUS/TLS. Furthermore, a common FUS/TLS mutant-associated RNA splicing signature is identified in ALS patient fibroblasts. Taken together, these studies establish potentially converging disease mechanisms in ALS and spinal muscular atrophy, with ALS-causative mutants acquiring properties representing both gain (dysregulation of SMN) and loss (reduced RNA processing mediated by U1-snRNP) of function.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:17820644